FindTrial
Sign In

Prevalence of T3 toxicosis of thyrotoxicosis patients in Thai population

Prevalence of T3 toxicosis of thyrotoxicosis patients in Thai population

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20180129008
Enrollment
Unknown
Registered
2018-01-29
Start date
2015-04-09
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patients who had signs and symptoms of thyrotoxicosis and had result of blood test at Siriraj hospital Thyrotoxicosis&#44

Interventions

The patients who had signs and symptoms of thyrotoxicosis and had result of blood test at Siriraj hospital
Diagnostic
Thyrotoxicosis patients

Sponsors

None
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 18 years old patient or older who was first diagnosed with thyrotoxicosis at OPD of Siriraj hospital during January 2009 to December 2013. At least 3 thyroid hormones including TSH, T3 and T4 (either total or free form) must be measured

Exclusion criteria

Exclusion criteria: the patient who was pregnant, receiving medication that could interrupt the hormone level including Levothyroxine, anti-thyroid drug, Amiodarone, Lithium, , Peg IFN within past 3 months.

Design outcomes

Primary

MeasureTime frame
Prevalence of T3 thyrorotoxicosis during January 2009 to December 2013 Measure FT3, FT4 and TSH at diagnosis—

Secondary

MeasureTime frame
N/A N/A N/A—

Countries

Thailand

Contacts

Public ContactTada Kunavisarut

Mahidol University

kunavisarut@gmail.com0843878300

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026